rs727505298

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_001039141.3(TRIOBP):​c.4271T>C​(p.Leu1424Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000019 in 1,581,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1424V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

19

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.32

Publications

0 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.042533964).
BP6
Variant 22-37734607-T-C is Benign according to our data. Variant chr22-37734607-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 180031.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.4271T>C p.Leu1424Pro missense_variant Exon 9 of 24 ENST00000644935.1 NP_001034230.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.4271T>C p.Leu1424Pro missense_variant Exon 9 of 24 NM_001039141.3 ENSP00000496394.1
TRIOBPENST00000344404.10 linkn.*3754T>C non_coding_transcript_exon_variant Exon 7 of 22 2 ENSP00000340312.6
TRIOBPENST00000344404.10 linkn.*3754T>C 3_prime_UTR_variant Exon 7 of 22 2 ENSP00000340312.6

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
151870
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000140
AC:
2
AN:
1429978
Hom.:
0
Cov.:
36
AF XY:
0.00
AC XY:
0
AN XY:
708712
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32944
American (AMR)
AF:
0.00
AC:
0
AN:
39082
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25488
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82846
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.00000182
AC:
2
AN:
1096446
Other (OTH)
AF:
0.00
AC:
0
AN:
59174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
151870
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74168
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
41304
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4800
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67938
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Sep 16, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu1424Pro in exon 9 of TRIOBP: This variant is not expected to have clinical s ignificance due to a lack of conservation across species, including mammals. Of note, green monkey, chinchilla, rabbit, pig, cat, David's myotis bat, microbat, armadillo, and platypus have a proline (Pro) at this position despite high near by amino acid conservation. In addition, computational prediction tools do not suggest a high likelihood of impact to the protein. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
1.4
DANN
Benign
0.73
DEOGEN2
Benign
0.011
T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0054
N
LIST_S2
Benign
0.28
.;T
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.043
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.83
L;L
PhyloP100
-2.3
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-1.0
N;.
REVEL
Benign
0.012
Sift
Benign
0.072
T;.
Sift4G
Benign
0.18
T;.
Polyphen
0.0060
B;B
Vest4
0.11
MutPred
0.13
Gain of catalytic residue at P1423 (P = 0.0119);Gain of catalytic residue at P1423 (P = 0.0119);
MVP
0.20
MPC
0.19
ClinPred
0.042
T
GERP RS
-4.1
Varity_R
0.086
gMVP
0.080
Mutation Taster
=95/5
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727505298; hg19: chr22-38130614; API